Literature DB >> 19077178

Behavioral characterization of mice lacking the neurite outgrowth inhibitor Nogo-A.

R Willi1, E M Aloy, B K Yee, J Feldon, M E Schwab.   

Abstract

The membrane protein Nogo-A inhibits neurite outgrowth and regeneration in the injured central nervous system, primarily because of its expression in oligodendrocytes. Hence, deletion of Nogo-A enhances regeneration following spinal cord injury. Yet, the effects of Nogo-A deletion on general behavior and cognition have not been explored. The possibility of potential novel functions of Nogo-A beyond growth inhibition is strongly suggested by the presence of subpopulations of neurons also expressing Nogo-A - not only during development but also in adulthood. We evaluated here Nogo-A(-/-) mice in a series of general basic behavioral assays as well as functional analyses related to brain regions with notable expression levels of Nogo-A. The SHIRPA protocol did not show any major basic behavioral changes in Nogo-A(-/-) mice. Anxiety-related behavior, pain sensitivity, startle reactivity, spatial learning, and associative learning also appeared indistinguishable between Nogo-A(-/-) and control Nogo-A(+/+) mice. However, motor co-ordination and balance were enhanced in Nogo-A(-/-) mice. Spontaneous locomotor activity was also elevated in Nogo-A(-/-) mice, but this was specifically observed in the dark (active) phase of the circadian cycle. Enhanced locomotor reaction to systemic amphetamine in Nogo-A(-/-) mice further pointed to an altered dopaminergic tone in these mice. The present study is the first behavioral characterization of mice lacking Nogo-A and provides significant insights into the potential behavioral relevance of Nogo-A in the modulation of dopaminergic and motor functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19077178     DOI: 10.1111/j.1601-183X.2008.00460.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  12 in total

1.  Role of Nogo-A in neuronal survival in the reperfused ischemic brain.

Authors:  Ertugrul Kilic; Ayman ElAli; Ulkan Kilic; Zeyun Guo; Milas Ugur; Unal Uslu; Claudio L Bassetti; Martin E Schwab; Dirk M Hermann
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

2.  Neuronal Nogo-A negatively regulates dendritic morphology and synaptic transmission in the cerebellum.

Authors:  Marija M Petrinovic; Raphael Hourez; Elisabeth M Aloy; Gregoire Dewarrat; David Gall; Oliver Weinmann; Julien Gaudias; Lukas C Bachmann; Serge N Schiffmann; Kaspar E Vogt; Martin E Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-31       Impact factor: 11.205

Review 3.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

4.  Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes.

Authors:  Roman Willi; Oliver Weinmann; Christine Winter; Julia Klein; Reinhard Sohr; Lisa Schnell; Benjamin K Yee; Joram Feldon; Martin E Schwab
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

5.  Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function.

Authors:  Björn Tews; Kai Schönig; Michael E Arzt; Stefano Clementi; Mengia-Seraina Rioult-Pedotti; Ajmal Zemmar; Stefan M Berger; Miriam Schneider; Thomas Enkel; Oliver Weinmann; Hansjörg Kasper; Martin E Schwab; Dusan Bartsch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

6.  Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice.

Authors:  N Marklund; D Morales; F Clausen; A Hånell; O Kiwanuka; A Pitkänen; D A Gimbel; O Philipson; L Lannfelt; L Hillered; S M Strittmatter; T K McIntosh
Journal:  Neuroscience       Date:  2009-06-23       Impact factor: 3.590

7.  Cognitive recovery in the aged rat after stroke and anti-Nogo-A immunotherapy.

Authors:  Rebecca L Gillani; Shih-Yen Tsai; Douglas G Wallace; Timothy E O'Brien; Ebinehita Arhebamen; Mateo Tole; Martin E Schwab; Gwendolyn L Kartje
Journal:  Behav Brain Res       Date:  2009-12-24       Impact factor: 3.332

8.  Nogo-A and its functions beyond axonal inhibition: the controversial role of Nogo-A in Parkinson's disease.

Authors:  Stefanie Seiler; Hans R Widmer
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

9.  Nogo-A-deficient Transgenic Rats Show Deficits in Higher Cognitive Functions, Decreased Anxiety, and Altered Circadian Activity Patterns.

Authors:  Tomas Petrasek; Iva Prokopova; Martin Sladek; Kamila Weissova; Iveta Vojtechova; Stepan Bahnik; Anna Zemanova; Kai Schönig; Stefan Berger; Björn Tews; Dusan Bartsch; Martin E Schwab; Alena Sumova; Ales Stuchlik
Journal:  Front Behav Neurosci       Date:  2014-03-18       Impact factor: 3.558

10.  Reduced expression of nogo-a leads to motivational deficits in rats.

Authors:  Thomas Enkel; Stefan M Berger; Kai Schönig; Björn Tews; Dusan Bartsch
Journal:  Front Behav Neurosci       Date:  2014-01-22       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.